Nisa Investment Advisors LLC cut its holdings in Aflac Incorporated (NYSE:AFL – Free Report) by 3.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 206,767 shares of the financial services provider’s stock after selling 6,774 shares during the period. Nisa Investment Advisors LLC’s holdings in Aflac were worth $23,112,000 at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Revisor Wealth Management LLC lifted its stake in shares of Aflac by 2.5% in the 3rd quarter. Revisor Wealth Management LLC now owns 4,802 shares of the financial services provider’s stock valued at $573,000 after purchasing an additional 119 shares during the last quarter. Bank Pictet & Cie Europe AG increased its position in shares of Aflac by 5.9% during the 3rd quarter. Bank Pictet & Cie Europe AG now owns 6,040 shares of the financial services provider’s stock worth $675,000 after purchasing an additional 334 shares during the last quarter. Kenora Financial LLC increased its position in shares of Aflac by 0.6% during the 3rd quarter. Kenora Financial LLC now owns 35,978 shares of the financial services provider’s stock worth $4,022,000 after purchasing an additional 213 shares during the last quarter. Focused Alpha LLC increased its position in shares of Aflac by 4.9% during the 3rd quarter. Focused Alpha LLC now owns 4,752 shares of the financial services provider’s stock worth $531,000 after purchasing an additional 224 shares during the last quarter. Finally, Retirement Planning Group LLC raised its holdings in Aflac by 2.9% in the 3rd quarter. Retirement Planning Group LLC now owns 4,359 shares of the financial services provider’s stock valued at $487,000 after buying an additional 122 shares during the period. 67.44% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
AFL has been the topic of a number of recent analyst reports. TD Cowen reaffirmed a “hold” rating and issued a $110.00 target price (up from $101.00) on shares of Aflac in a research report on Wednesday, July 22nd. Piper Sandler reaffirmed an “overweight” rating and set a $138.00 target price (up from $130.00) on shares of Aflac in a research note on Monday, August 10th. Mizuho dropped their price target on shares of Aflac from $116.00 to $107.00 and set an “underperform” rating for the company in a research report on Wednesday, October 7th. UBS Group reissued a “neutral” rating and issued a $125.00 price target (up from $124.00) on shares of Aflac in a research note on Tuesday, October 6th. Finally, Evercore boosted their price target on shares of Aflac from $109.00 to $115.00 and gave the company an “underperform” rating in a research note on Monday, July 13th. Four research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $117.20.
Get Our Latest Analysis on Aflac
Insider Buying and Selling
In related news, major shareholder Post Holdings Co. Ltd. Japan sold 113,611 shares of the firm’s stock in a transaction dated Thursday, October 15th. The stock was sold at an average price of $118.53, for a total transaction of $13,466,311.83. Following the completion of the transaction, the insider directly owned 50,134,329 shares in the company, valued at $5,942,422,016.37. This trade represents a 0.23% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 713,662 shares of company stock worth $83,323,978. Company insiders own 0.80% of the company’s stock.
Aflac Stock Down 0.1%
NYSE:AFL opened at $120.12 on Thursday. Aflac Incorporated has a 52 week low of $105.43 and a 52 week high of $130.22. The stock’s fifty day moving average is $116.28 and its two-hundred day moving average is $117.47. The stock has a market capitalization of $60.22 billion, a price-to-earnings ratio of 12.87, a price-to-earnings-growth ratio of 1.90 and a beta of 0.56. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 0.29.
Aflac (NYSE:AFL – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The financial services provider reported $1.75 earnings per share for the quarter, missing analysts’ consensus estimates of $1.76 by ($0.01). Aflac had a net margin of 26.91% and a return on equity of 13.27%. The firm had revenue of $4.22 billion during the quarter, compared to analyst estimates of $4.11 billion. During the same period in the previous year, the firm posted $1.78 earnings per share. The company’s quarterly revenue was down 1.0% compared to the same quarter last year. Research analysts anticipate that Aflac Incorporated will post 7.04 EPS for the current year.
Aflac Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 1st. Investors of record on Wednesday, August 19th were paid a dividend of $0.61 per share. The ex-dividend date of this dividend was Wednesday, August 19th. This represents a $2.44 annualized dividend and a yield of 2.0%. Aflac’s dividend payout ratio is presently 26.15%.
Aflac Profile
Aflac Incorporated (NYSE:AFL) is an insurance company specializing in supplemental health and life insurance. Through its policies, the company helps individuals and families manage expenses that may not be fully covered by major medical insurance, including deductibles, copayments and other out-of-pocket costs.
Aflac offers products such as accident, cancer, critical illness, hospital indemnity, dental and vision, disability, life and long-term care insurance. Many of its supplemental policies provide cash benefits directly to policyholders, who can generally use the funds according to their individual needs.
Read More
- Five stocks we like better than Aflac
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
